Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

A Study of ICP-022 in Patients With R/R DLBCL

NCT04438005

Conditions
Diffuse Large B Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Affiliated Tumor Hospital of Harbin Medical University Haerbin, Heilongjiang, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Shengjing Hospital of China Medical University Shenyang, Liaoning, China
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

NCT02445248

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • UCSF Medical Center . San Francisco, California, United States
  • Emory University School of Medicine/Winship Cancer Institute SC CTL019 Atlanta, Georgia, United States
  • University of Chicago Medical Center Hematology and Oncology SC - CTL019B2207J Chicago, Illinois, United States
  • University of Kansas Cancer Center SC - CTL019C2201 Westwood, Kansas, United States
View all 26 locations
View Trial Details
Completed

A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies

NCT03310619

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Local Institution - 011 Duarte, California, United States
  • Local Institution - 022 Atlanta, Georgia, United States
  • Local Institution - 014 Chicago, Illinois, United States
  • Local Institution - 012 Boston, Massachusetts, United States
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

NCT01897571

Conditions
Advanced Solid Tumors (Phase 1), B-cell Lymphomas (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2), +15 more
Locations
  • Birmingham, Alabama, United States
  • Duarte, California, United States
  • Santa Barbara, California, United States
  • Aurora, Colorado, United States
View all 52 locations
View Trial Details

Related conditions